Similarly, CEA levels can be influenced by malignancies such as colorectal cancer, breast cancer, and non-small-cell lung cancer (NSCLC), as well as benign factors like liver and biliary dysfunction (4, 5). This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.